Search alternatives:
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1241
-
1242
-
1243
-
1244
-
1245
-
1246
-
1247
-
1248
-
1249
Hematopoietic potential decreases in ESC with down-regulation of junction molecules.
Published 2011“…D) Day 5 EB with knockdown of E-cadherin, Cx43, ZO-1 and ZO-2 were dissociated and replated as single cells to determine colony forming potential. …”
-
1250
HDAC1 knockdown decreases cell proliferation in the optic tectum.
Published 2015“…There was no significant change in BrdU- or BLBP-labeled tectal cells electroporated with Ctrl-MO (E, F). (BrdU: Ctrl, 163.2 ± 7.9, N = 5, Ctrl-MO, 183.0 ± 14.6, N = 4, HDAC1-MO, 120.0 ± 8.5, N = 5; BLBP: Ctrl, 179.2 ± 7.2, N = 5, Ctrl-MO, 176.5 ± 11.5, N = 4, HDAC1-MO, 125.2 ± 8.4, N = 5; **p<0.01). …”
-
1251
-
1252
-
1253
-
1254
Retinoschisin secretion into the conditioned medium is decreased by addition of cytochalasin D.
Published 2013“…(D) Retinoschisin secretion decreases in a dose-dependent manner by treatment of cells with cytochalasin D at concentrations between 0.5 µM and 2 µM. …”
-
1255
Exogenous activation of BMP signaling decreases apoptosis in POb cells.
Published 2013“…BMP-2 treatment decreases apoptosis markedly in POb cells compared to untreated POb, a lower apoptotic activity is also observed in BMP-2 treated FOb as compared to untreated FOb cells. …”
-
1256
-
1257
-
1258
-
1259
-
1260